Cyclobenzaprine Hydrochloride Patent Expiration
Cyclobenzaprine Hydrochloride is Used for relieving muscle spasms. It was first introduced by Janssen Research And Development Llc
Cyclobenzaprine Hydrochloride Patents
Given below is the list of patents protecting Cyclobenzaprine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amrix | US7387793 | Modified release dosage forms of skeletal muscle relaxants |
Feb 26, 2025
(Expired) | Teva Pharms Intl |
| Amrix | US7544372 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US7790199 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US7820203 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US7829121 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US8877245 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US9375410 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
| Amrix | US9399025 | Modified release dosage forms of skeletal muscle relaxants |
Nov 14, 2023
(Expired) | Teva Pharms Intl |
Cyclobenzaprine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List